{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T22:29:17Z","timestamp":1792621757621,"version":"4.5.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T00:00:00Z","timestamp":1611878400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T00:00:00Z","timestamp":1611878400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Endothelial damage and fibro-proliferative vasculopathy of small vessels are pathological hallmarks of systemic sclerosis (SSc). The consequence is the detachment of resident elements that become circulating endothelial cells (CECs). The aim of our study was to evaluate the potential of CECs as biomarker in SSc. We enrolled 50 patients with limited cutaneous (lcSSc) and diffuse cutaneous (dcSSc) subset of SSc, who underwent clinical evaluation to establish the organ involvement. CECs were measured by flow-cytometry utilizing a polychromatic panel. An evident difference was observed in CEC counts comparing controls to SSc patients (median 10.5 vs. 152 cells\/ml, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001) and for the first time, between the two subsets of disease (median lcSSc 132 vs. dcSSc 716 CEC\/ml, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001). A significant correlation was established between CECs and some SSc clinical parameters, such as digital ulcers, skin and pulmonary involvement, presence of Scl-70 antibodies, nailfold videocapillaroscopy patterns and EUSTAR activity index. After 12\u00a0months, CECs correlated with clinical worsening of patients, showing that a number higher than 414 CEC\/ml is a strong negative prognostic factor (RR 5.70). Our results indicate that CECs are a direct indicator of systemic vascular damage. Therefore, they can be used as a reliable marker of disease severity.<\/jats:p>","DOI":"10.1038\/s41598-020-80604-7","type":"journal-article","created":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T11:19:10Z","timestamp":1611919150000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Role of circulating endothelial cells in assessing the severity of systemic sclerosis and predicting its clinical worsening"],"prefix":"10.1038","volume":"11","author":[{"given":"Maria Luisa","family":"Di Martino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Frau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Losa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Muggianu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario Nicola","family":"Mura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Rotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenza","family":"Scotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Marongiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,29]]},"reference":[{"key":"80604_CR1","doi-asserted-by":"publisher","unstructured":"Pattanaik, D., Brown, M., Postlethwaite, B.C. & Arnold, E. Postlethwaite Pathogenesis of systemic sclerosis. Front. Immunol. 6, 272; https:\/\/doi.org\/10.3389\/fimmu.2015.00272 (2015).","DOI":"10.3389\/fimmu.2015.00272"},{"key":"80604_CR2","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","volume":"390","author":"CP Denton","year":"2017","unstructured":"Denton, C. P. & Khanna, D. Systemic sclerosis. Lancet 390, 1685\u20131699 (2017).","journal-title":"Lancet"},{"key":"80604_CR3","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.autrev.2016.01.007","volume":"15","author":"AC Desbois","year":"2016","unstructured":"Desbois, A. C. & Cacoub, P. Systemic sclerosis: an update in 2016. Autoimmun. Rev. 15, 417\u2013426 (2016).","journal-title":"Autoimmun. Rev."},{"issue":"11","key":"80604_CR4","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","volume":"72","author":"F Van den Hoogen","year":"2013","unstructured":"Van den Hoogen, F. et al. 2013 classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative. Ann. Rheum. Dis. 72(11), 1747\u20131755 (2013).","journal-title":"Ann. Rheum. Dis."},{"key":"80604_CR5","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1111\/j.1582-4934.2010.01027.x","volume":"14","author":"M Manetti","year":"2010","unstructured":"Manetti, M., Guiducci, S., Ibba-Manneschi, L. & Matucci-Cerinic, M. Mechanisms in the loss of capillaries in systemic sclerosis: angiogenesis versus vasculogenesis. J. Cell Mol. Med. 14, 1241\u20131254 (2010).","journal-title":"J. Cell Mol. Med."},{"key":"80604_CR6","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.autrev.2011.04.016","volume":"10","author":"P Cipriani","year":"2011","unstructured":"Cipriani, P., Marrelli, A., Liakouli, V., Di Benedetto, P. & Giacomelli, R. Cellular players in angiogenesis during the course of systemic sclerosis. Autoimmun. Rev. 10, 641\u2013646 (2011).","journal-title":"Autoimmun. Rev."},{"issue":"2","key":"80604_CR7","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1160\/TH04-09-0578","volume":"93","author":"AD Blann","year":"2005","unstructured":"Blann, A. D. et al. Circulating endothelial cells. Biomarker of vascular disease. Thromb. Haemost. 93(2), 228\u2013235 (2005).","journal-title":"Thromb. Haemost."},{"key":"80604_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/cyto.b.20040","volume":"64","author":"SS Khan","year":"2005","unstructured":"Khan, S. S., Solomon, M. A. & McCoy, J. P. Jr. Detection of circulating endothelial cells and endothelial progenitor cells by flow cytometry. Cytometry. B Clin. Cytom. 64, 1\u20138 (2005).","journal-title":"Cytometry. B Clin. Cytom."},{"key":"80604_CR9","doi-asserted-by":"publisher","first-page":"3658","DOI":"10.1182\/blood.V97.11.3658","volume":"97","author":"P Mancuso","year":"2001","unstructured":"Mancuso, P. et al. Resting and activated endothelial cells are increased in the peripheral blood of cancer patients. Blood 97, 3658\u20133661 (2001).","journal-title":"Blood"},{"key":"80604_CR10","doi-asserted-by":"publisher","first-page":"2951","DOI":"10.1182\/blood.V93.9.2951","volume":"93","author":"M Mutin","year":"1999","unstructured":"Mutin, M. et al. Direct evidence of endothelial injury in acute myocardial infarction and unstable angina by demonstration of circulating endothelial cells. Blood 93, 2951\u20132958 (1999).","journal-title":"Blood"},{"key":"80604_CR11","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1182\/blood-2004-03-1106","volume":"105","author":"KW Lee","year":"2005","unstructured":"Lee, K. W., Lip, G. Y., Tayebjee, M., Foster, W. & Blann, A. D. Circulating endothelial cells, von Willebrand factor, interleukin-6, and prognosis in patients with acute coronary syndromes. Blood 105, 526\u2013532 (2005).","journal-title":"Blood"},{"key":"80604_CR12","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1093\/ndt\/gfn650","volume":"24","author":"M Elshal","year":"2009","unstructured":"Elshal, M. et al. Quantification of circulating endothelial cells in peripheral blood of systemic lupus erythematosus patients: a simple and reproducible method of assessing endothelial injury and repair. Nephrol. Dials. Transpl. 24, 1495\u20131499 (2009).","journal-title":"Nephrol. Dials. Transpl."},{"key":"80604_CR13","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1160\/TH06-04-0185","volume":"96","author":"PK Goon","year":"2006","unstructured":"Goon, P. K., Boos, C. J., Stonelake, P. S., Blann, A. D. & Lip, G. Y. Detection and quantification of mature circulating endothelial cells using flow cytometry and immunomagnetic beads: a methodological comparison. Thromb. Haemost 96, 45\u201352 (2006).","journal-title":"Thromb. Haemost"},{"key":"80604_CR14","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1111\/j.1538-7836.2012.04681.x","volume":"10","author":"J Kraan","year":"2012","unstructured":"Kraan, J. et al. A new approach for rapid and reliable enumeration of circulating endothelial cells in patients. J. Thromb. Haemost. 10, 931\u2013939 (2012).","journal-title":"J. Thromb. Haemost."},{"key":"80604_CR15","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1158\/1078-0432.CCR-08-0432","volume":"15","author":"P Mancuso","year":"2009","unstructured":"Mancuso, P. et al. Validation of a standardized method for enumerating circulating endothelial cells and progenitors: flow cytometry and molecular and ultrastructural analyses. Clin. Cancer Res. 15, 267\u2013273 (2009).","journal-title":"Clin. Cancer Res."},{"key":"80604_CR16","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1161\/ATVBAHA.111.244210","volume":"32","author":"JA Mund","year":"2012","unstructured":"Mund, J. A., Estes, M. L., Yoder, M. C., Ingram, D. A. Jr. & Case, J. Flow cytometric identification and functional characterization of immature and mature circulating endothelial cells. Arterioscler. Thromb. Vasc. Biol. 32, 1045\u20131053 (2012).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"80604_CR17","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1002\/art.20116","volume":"50","author":"N Del Papa","year":"2004","unstructured":"Del Papa, N. et al. Circulating endothelial cells as a marker of ongoing vascular disease in systemic sclerosis. Arthritis Rheum. 50, 1296\u20131304 (2004).","journal-title":"Arthritis Rheum."},{"key":"80604_CR18","doi-asserted-by":"publisher","unstructured":"Avouac, J. et al. Correlations between angiogenic factors and capillaroscopic patterns in systemic sclerosis. Arthritis Res. Ther. 15, R55 https:\/\/doi.org\/10.1186\/ar4217 (2013).","DOI":"10.1186\/ar4217"},{"key":"80604_CR19","doi-asserted-by":"publisher","first-page":"5823","DOI":"10.1038\/s41598-018-24234-0","volume":"8","author":"P Lanuti","year":"2018","unstructured":"Lanuti, P. et al. A standardized flow cytometry network study for the assessment of circulating endothelial cell physiological ranges. Sci. Rep. 8, 5823 (2018).","journal-title":"Sci. Rep."},{"key":"80604_CR20","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1002\/cyto.a.22730","volume":"89","author":"P Lanuti","year":"2016","unstructured":"Lanuti, P. et al. Endothelial progenitor cells, defined by the simultaneous surface expression of VEGFR2 and CD133, are not detectable in healthy peripheral and cord blood. Cytometry A 89, 259\u2013270 (2016).","journal-title":"Cytometry A"},{"key":"80604_CR21","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.autrev.2012.05.011","volume":"12","author":"S Mehra","year":"2013","unstructured":"Mehra, S., Walker, J., Patterson, K. & Fritzler, M. J. Autoantibodies in systemic sclerosis. Autoimmun. Rev. 12, 340\u2013354 (2013).","journal-title":"Autoimmun. Rev."},{"key":"80604_CR22","first-page":"80","volume":"5","author":"KT Ho","year":"2003","unstructured":"Ho, K. T. & Reveille, J. D. The clinical relevance of autoantibodies in scleroderma. Arthritis. Res. Ther. 5, 80\u201393 (2003).","journal-title":"Arthritis. Res. Ther."},{"key":"80604_CR23","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/1346-8138.13156","volume":"43","author":"M Hasegawa","year":"2016","unstructured":"Hasegawa, M. Biomarkers in systemic sclerosis: their potential to predict clinical courses. J. Dermatol. 43, 29\u201338 (2016).","journal-title":"J. Dermatol."},{"key":"80604_CR24","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.autrev.2017.05.024","volume":"16","author":"Y Mostmans","year":"2017","unstructured":"Mostmans, Y. et al. The role of endothelial cells in the vasculopathy of systemic sclerosis: a systematic review. Autoimmun. Rev. 16, 774\u2013786 (2017).","journal-title":"Autoimmun. Rev."},{"key":"80604_CR25","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/j.autrev.2016.07.025","volume":"15","author":"A Morales-C\u00e1rdenas","year":"2016","unstructured":"Morales-C\u00e1rdenas, A. et al. Pulmonary involvement in systemic sclerosis. Autoimmun. Rev. 15, 1094\u20131108 (2016).","journal-title":"Autoimmun. Rev."},{"key":"80604_CR26","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1093\/rheumatology\/40.10.1135","volume":"40","author":"S Sato","year":"2001","unstructured":"Sato, S., Hamaguchi, Y., Hasegawa, M. & Takehara, K. Clinical significance of anti-topoisomerase I antibody levels determined by ELISA in systemic sclerosis. Rheumatology (Oxford) 40, 1135\u20131140 (2001).","journal-title":"Rheumatology (Oxford)"},{"key":"80604_CR27","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1136\/ard.2006.062901","volume":"66","author":"UA Walker","year":"2007","unstructured":"Walker, U. A. et al. Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group database. Ann. Rheum. Dis. 66, 754\u2013763 (2007).","journal-title":"Ann. Rheum. Dis."},{"key":"80604_CR28","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1093\/rheumatology\/keh067","volume":"43","author":"D Mukerjee","year":"2004","unstructured":"Mukerjee, D. et al. Echocardiography and pulmonary function as screening tests for pulmonary arterial hypertension in systemic sclerosis. Rheumatology (Oxford) 43, 461\u2013466 (2004).","journal-title":"Rheumatology (Oxford)"},{"key":"80604_CR29","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1186\/s12891-016-1206-5","volume":"17","author":"LA Bissell","year":"2016","unstructured":"Bissell, L. A., Abignano, G., Emery, P., Del Galdo, F. & Burch, M. H. Absence of Scleroderma pattern at nail fold capillaroscopy valuable in the exclusion of Scleroderma in unselected patients with Raynaud\u2019s Phenomenon. BMC Musculoskelet. Disord. 17, 342 (2016).","journal-title":"BMC Musculoskelet. Disord."},{"key":"80604_CR30","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1136\/annrheumdis-2016-209909","volume":"76","author":"O Bielecka","year":"2017","unstructured":"Bielecka, O. et al. Update of EULAR recommendations for the treatment of systemic sclerosis. Ann. Rheum. Dis. 76, 1327\u20131339 (2017).","journal-title":"Ann. Rheum. Dis."},{"key":"80604_CR31","first-page":"503","volume":"19","author":"R Scorza","year":"2001","unstructured":"Scorza, R. et al. Effects of long-term cyclic iloprost therapy in systemic sclerosis with Raynaud\u2019s phenomenon. A randomized, controlled study. Clin. Exp. Rheumatol. 19, 503\u2013508 (2001).","journal-title":"Clin. Exp. Rheumatol."},{"issue":"8","key":"80604_CR32","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.1002\/art.24681","volume":"60","author":"S Amjadi","year":"2009","unstructured":"Amjadi, S. et al. Course of modified rodnan skin score in systemic sclerosis clinical trials: analysis of 3 large multicenter, randomized clinical trials. Arthritis Rheum. 60(8), 2490\u20132498 (2009).","journal-title":"Arthritis Rheum."},{"key":"80604_CR33","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1136\/annrheumdis-2016-209768","volume":"76","author":"G Valentini","year":"2017","unstructured":"Valentini, G. et al. The European Scleroderma Trials and Research group (EUSTAR) task force for the development of revised activity criteria for systemic sclerosis: derivation and validation of a preliminarily revised EUSTAR activity index. Ann. Rheum. Dis. 76, 270\u2013276 (2017).","journal-title":"Ann. Rheum. Dis."},{"key":"80604_CR34","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/S0001-2998(95)80004-2","volume":"25","author":"HA Klein","year":"1995","unstructured":"Klein, H. A. Esophageal transit scintigraphy. Semin. Nucl. Med. 25, 306\u2013317 (1995).","journal-title":"Semin. Nucl. Med."},{"key":"80604_CR35","first-page":"155","volume":"27","author":"M Cutolo","year":"2000","unstructured":"Cutolo, M., Sulli, A., Pizzorni, C. & Accardo, S. Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. J. Rheumatol. 27, 155\u2013160 (2000).","journal-title":"J. Rheumatol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-80604-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-80604-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-80604-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T02:44:09Z","timestamp":1670035449000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-80604-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,29]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["80604"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-80604-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,29]]},"assertion":[{"value":"29 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Gianluca Rotta is an employee of BDBiosciences Italy, Lyotubes where purchased from this company. The other authors do not have any duality of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2681"}}